These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 18334280)

  • 61. [Identification and clinical evaluation of lung cancer serum biomarker L-lactate dehydrogenase B].
    Chen Y; Zhang H; Xu AJ; Liu JF; Li N; Wu SS; Huang LY; He DC; Xiao XY
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Aug; 30(8):577-81. PubMed ID: 17988549
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Proteomics for the identification of new prostate cancer biomarkers.
    Ornstein DK; Tyson DR
    Urol Oncol; 2006; 24(3):231-6. PubMed ID: 16678055
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Secretome-based identification of Mac-2 binding protein as a potential oral cancer marker involved in cell growth and motility.
    Weng LP; Wu CC; Hsu BL; Chi LM; Liang Y; Tseng CP; Hsieh LL; Yu JS
    J Proteome Res; 2008 Sep; 7(9):3765-75. PubMed ID: 18646789
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Profiling protein markers associated with the sensitivity to concurrent chemoradiotherapy in human cervical carcinoma.
    Zhu H; Pei HP; Zeng S; Chen J; Shen LF; Zhong MZ; Yao RJ; Shen H
    J Proteome Res; 2009 Aug; 8(8):3969-76. PubMed ID: 19507834
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
    Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Profiling of nuclear extract proteins from human neuroblastoma cell lines: the search for fingerprints.
    Escobar MA; Hoelz DJ; Sandoval JA; Hickey RJ; Grosfeld JL; Malkas LH
    J Pediatr Surg; 2005 Feb; 40(2):349-58. PubMed ID: 15750928
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dickkopf-1 expression as a marker for predicting clinical outcome in esophageal squamous cell carcinoma.
    Makino T; Yamasaki M; Takemasa I; Takeno A; Nakamura Y; Miyata H; Takiguchi S; Fujiwara Y; Matsuura N; Mori M; Doki Y
    Ann Surg Oncol; 2009 Jul; 16(7):2058-64. PubMed ID: 19408050
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Identification of GRP75 as an independent favorable prognostic marker of neuroblastoma by a proteomics analysis.
    Hsu WM; Lee H; Juan HF; Shih YY; Wang BJ; Pan CY; Jeng YM; Chang HH; Lu MY; Lin KH; Lai HS; Chen WJ; Tsay YG; Liao YF; Hsieh FJ
    Clin Cancer Res; 2008 Oct; 14(19):6237-45. PubMed ID: 18829503
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of potential plasma biomarkers for esophageal squamous cell carcinoma by a proteomic method.
    Zhao J; Fan YX; Yang Y; Liu DL; Wu K; Wen FB; Zhang CY; Zhu DY; Zhao S
    Int J Clin Exp Pathol; 2015; 8(2):1535-44. PubMed ID: 25973038
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.
    Zhou SL; Yue WB; Fan ZM; Du F; Liu BC; Li B; Han XN; Ku JW; Zhao XK; Zhang P; Cui J; Zhou FY; Zhang LQ; Fan XP; Zhou YF; Zhu LL; Liu HY; Wang LD
    Dis Esophagus; 2014; 27(8):790-7. PubMed ID: 24147952
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Serum proteomics study of the squamous cell carcinoma antigen 1 in tongue cancer.
    Huang X; Wei Y; Li L; Wen Y; Yang J; Liu B; Song X; Zhao J
    Oral Oncol; 2006 Jan; 42(1):26-31. PubMed ID: 16143561
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.
    Xu G; Xiang CQ; Lu Y; Kang XN; Liao P; Ding Q; Zhang YF
    Cancer Lett; 2009 Sep; 282(2):205-13. PubMed ID: 19362769
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Proteomic analysis of two head and neck cancer cell lines presenting different radiation sensitivity.
    Lee YS; Chang HW; Jeong JE; Lee SW; Kim SY
    Acta Otolaryngol; 2008 Jan; 128(1):86-92. PubMed ID: 17917836
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Identification and confirmation of increased fibrinopeptide a serum protein levels in gastric cancer sera by magnet bead assisted MALDI-TOF mass spectrometry.
    Ebert MP; Niemeyer D; Deininger SO; Wex T; Knippig C; Hoffmann J; Sauer J; Albrecht W; Malfertheiner P; Röcken C
    J Proteome Res; 2006 Sep; 5(9):2152-8. PubMed ID: 16944926
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer.
    Chen Y; Zhang H; Xu A; Li N; Liu J; Liu C; Lv D; Wu S; Huang L; Yang S; He D; Xiao X
    Lung Cancer; 2006 Oct; 54(1):95-102. PubMed ID: 16890323
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Proteomics-based identification of autoantibodies in the sera of healthy Chinese individuals from Beijing.
    Li WH; Zhao J; Li HY; Liu H; Li AL; Wang HX; Wang J; He K; Liang B; Yu M; Shen BF; Zhang XM
    Proteomics; 2006 Sep; 6(17):4781-9. PubMed ID: 16878294
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Proteomic-based analysis for identification of potential serum biomarkers in gallbladder cancer.
    Tan Y; Ma SY; Wang FQ; Meng HP; Mei C; Liu A; Wu HR
    Oncol Rep; 2011 Oct; 26(4):853-9. PubMed ID: 21687958
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparative proteomic analysis of the esophageal squamous carcinoma cell line EC109 and its multi-drug resistant subline EC109/CDDP.
    Wen J; Zheng B; Hu Y; Zhang X; Yang H; Li Y; Zhang CY; Luo KJ; Zang X; Li YF; Guan XY; Fu JH
    Int J Oncol; 2010 Jan; 36(1):265-74. PubMed ID: 19956855
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Proteomic analysis of autoantibodies in patients with hepatocellular carcinoma.
    Takashima M; Kuramitsu Y; Yokoyama Y; Iizuka N; Harada T; Fujimoto M; Sakaida I; Okita K; Oka M; Nakamura K
    Proteomics; 2006 Jul; 6(13):3894-900. PubMed ID: 16767786
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Role of serum angiopoietin-2 level in screening for esophageal squamous cell cancer and its precursors.
    Zhou YZ; Fang XQ; Li H; Diao YT; Yang YF; Zhao DL; Wu K; Li HQ
    Chin Med J (Engl); 2007 Jul; 120(14):1216-9. PubMed ID: 17697570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.